Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dianthus Therapeutics (DNTH) Other Accumulated Expenses (2022 - 2023)

Historic Other Accumulated Expenses for Dianthus Therapeutics (DNTH) over the last 2 years, with Q2 2023 value amounting to $279000.0.

  • Dianthus Therapeutics' Other Accumulated Expenses changed N/A to $279000.0 in Q2 2023 from the same period last year, while for Jun 2023 it was $279000.0, marking a year-over-year change of. This contributed to the annual value of $364000.0 for FY2022, which is N/A changed from last year.
  • Latest data reveals that Dianthus Therapeutics reported Other Accumulated Expenses of $279000.0 as of Q2 2023.
  • In the past 5 years, Dianthus Therapeutics' Other Accumulated Expenses ranged from a high of $364000.0 in Q4 2022 and a low of $224000.0 during Q1 2023